Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 12:44:32 UTC
Update Date2021-09-26 23:07:21 UTC
HMDB IDHMDB0253848
Secondary Accession NumbersNone
Metabolite Identification
Common Name(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide
Description(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide belongs to the class of organic compounds known as phenylpiperazines. Phenylpiperazines are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. Based on a literature review very few articles have been published on (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2s)-2-amino-n-[(1s)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulphonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulphonylbutanamideGenerator
Chemical FormulaC26H42N4O5S2
Average Molecular Weight554.77
Monoisotopic Molecular Weight554.259662816
IUPAC Name2-amino-N-[7,7-dimethyl-1-({[4-(2-methylphenyl)piperazin-1-yl]sulfonyl}methyl)bicyclo[2.2.1]heptan-2-yl]-4-methanesulfonylbutanamide
Traditional Name2-amino-N-(7,7-dimethyl-1-{[4-(2-methylphenyl)piperazin-1-ylsulfonyl]methyl}bicyclo[2.2.1]heptan-2-yl)-4-methanesulfonylbutanamide
CAS Registry NumberNot Available
SMILES
CC1=CC=CC=C1N1CCN(CC1)S(=O)(=O)CC12CCC(CC1NC(=O)C(N)CCS(C)(=O)=O)C2(C)C
InChI Identifier
InChI=1S/C26H42N4O5S2/c1-19-7-5-6-8-22(19)29-12-14-30(15-13-29)37(34,35)18-26-11-9-20(25(26,2)3)17-23(26)28-24(31)21(27)10-16-36(4,32)33/h5-8,20-21,23H,9-18,27H2,1-4H3,(H,28,31)
InChI KeyMWIASLNTAGRGGA-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenylpiperazines. Phenylpiperazines are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazinanes
Sub ClassPiperazines
Direct ParentPhenylpiperazines
Alternative Parents
Substituents
  • Alpha-amino acid amide
  • Phenylpiperazine
  • N-arylpiperazine
  • Alpha-amino acid or derivatives
  • Aromatic monoterpenoid
  • Norbornane monoterpenoid
  • Bornane monoterpenoid
  • Monoterpenoid
  • Bicyclic monoterpenoid
  • Aminotoluene
  • Aniline or substituted anilines
  • Dialkylarylamine
  • Tertiary aliphatic/aromatic amine
  • Toluene
  • Benzenoid
  • Organosulfonic acid amide
  • Organic sulfonic acid amide
  • Fatty amide
  • Fatty acyl
  • Monocyclic benzene moiety
  • N-acyl-amine
  • Sulfonyl
  • Organosulfonic acid or derivatives
  • Organic sulfonic acid or derivatives
  • Sulfone
  • Amino acid or derivatives
  • Tertiary amine
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Carboxylic acid derivative
  • Azacycle
  • Primary aliphatic amine
  • Organic nitrogen compound
  • Amine
  • Carbonyl group
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Primary amine
  • Organosulfur compound
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.56ALOGPS
logP0.28ChemAxon
logS-4.1ALOGPS
pKa (Strongest Acidic)14.92ChemAxon
pKa (Strongest Basic)7.6ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area129.88 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity145.95 m³·mol⁻¹ChemAxon
Polarizability60.21 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-247.97930932474
DeepCCS[M+Na]+223.40430932474
AllCCS[M+H]+226.132859911
AllCCS[M+H-H2O]+225.032859911
AllCCS[M+NH4]+227.132859911
AllCCS[M+Na]+227.332859911
AllCCS[M-H]-207.132859911
AllCCS[M+Na-2H]-209.432859911
AllCCS[M+HCOO]-212.032859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Predicted by Siyang on May 30, 202215.0245 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20223.57 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2596.2 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid170.1 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid231.9 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid162.8 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid157.9 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid581.7 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid546.2 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)149.2 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1264.8 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid550.5 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1739.7 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid385.3 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid423.3 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate206.2 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA144.4 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water8.3 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamideCC1=CC=CC=C1N1CCN(CC1)S(=O)(=O)CC12CCC(CC1NC(=O)C(N)CCS(C)(=O)=O)C2(C)C6151.6Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamideCC1=CC=CC=C1N1CCN(CC1)S(=O)(=O)CC12CCC(CC1NC(=O)C(N)CCS(C)(=O)=O)C2(C)C4301.8Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamideCC1=CC=CC=C1N1CCN(CC1)S(=O)(=O)CC12CCC(CC1NC(=O)C(N)CCS(C)(=O)=O)C2(C)C4637.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)C3(C)C)CC14559.7Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)C3(C)C)CC14519.2Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)C3(C)C)CC15573.2Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C)C3(C)C)CC14412.9Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C)C3(C)C)CC14513.1Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C)C3(C)C)CC16085.8Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC14387.6Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC14659.9Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC15344.5Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC14589.2Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC14753.6Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC15427.1Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC14443.7Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC14882.4Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC15166.2Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)C3(C)C)CC14789.8Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)C3(C)C)CC14804.8Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)C3(C)C)CC15593.8Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C(C)(C)C)C3(C)C)CC14673.5Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C(C)(C)C)C3(C)C)CC14791.2Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C(C)(C)C)C3(C)C)CC16087.0Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC14875.8Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC15195.7Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC15396.8Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC14992.4Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC15247.6Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #2CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC15437.0Standard polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC15083.0Semi standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC15610.4Standard non polar33892256
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TBDMS,isomer #1CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC15206.4Standard polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID14019685
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound21476314
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]